June 1, 2021

Crescendo to participate in upcoming investor conferences

CAMBRIDGE, England–(BUSINESS WIRE)–Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces that senior members of the executive team will be participating at the following three conferences to meet investors to discuss the Company’s business strategy, technology, discovery platform and development programmes. Kempen Life Sciences Crossover Conference (Virtual), 16 June 2021 JMP Securities Life Scie


Leave Comment


Your Name *
Your Email *
Your Website
Comment *